Publication:
Follicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies

dc.contributor.authorPetrovas, Constantinos
dc.contributor.authorFerrando-Martinez, Sara
dc.contributor.authorGerner, Michael Y.
dc.contributor.authorCasazza, Joseph P.
dc.contributor.authorPegu, Amarendra
dc.contributor.authorDeleage, Claire
dc.contributor.authorCooper, Arik
dc.contributor.authorHataye, Jason
dc.contributor.authorAndrews, Sarah
dc.contributor.authorAmbrozak, David
dc.contributor.authorDel Rio Estrada, Perla M.
dc.contributor.authorBoritz, Eli
dc.contributor.authorParis, Robert
dc.contributor.authorMoysi, Eirini
dc.contributor.authorBoswell, Kristin L.
dc.contributor.authorRuiz-Mateos, Ezequiel
dc.contributor.authorVagios, Ilias
dc.contributor.authorLeal, Manuel
dc.contributor.authorAblanedo-Terrazas, Yuria
dc.contributor.authorRivero, Amaranta
dc.contributor.authorAlicia Gonzalez-Hernandez, Luz
dc.contributor.authorMcDermott, Adrian B.
dc.contributor.authorMoir, Susan
dc.contributor.authorReyes-Teran, Gustavo
dc.contributor.authorDocobo, Fernando
dc.contributor.authorPantaleo, Giuseppe
dc.contributor.authorDouek, Daniel C.
dc.contributor.authorBetts, Michael R.
dc.contributor.authorEstes, Jacob D.
dc.contributor.authorGermain, Ronald N.
dc.contributor.authorMascola, John R.
dc.contributor.authorKoup, Richard A.
dc.contributor.authoraffiliation[Petrovas, Constantinos] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA
dc.contributor.authoraffiliation[Ferrando-Martinez, Sara] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA
dc.contributor.authoraffiliation[Casazza, Joseph P.] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA
dc.contributor.authoraffiliation[Hataye, Jason] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA
dc.contributor.authoraffiliation[Ambrozak, David] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA
dc.contributor.authoraffiliation[Moysi, Eirini] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA
dc.contributor.authoraffiliation[Boswell, Kristin L.] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA
dc.contributor.authoraffiliation[Koup, Richard A.] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA
dc.contributor.authoraffiliation[Gerner, Michael Y.] NIAID, Lab Syst Biol, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
dc.contributor.authoraffiliation[Germain, Ronald N.] NIAID, Lab Syst Biol, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
dc.contributor.authoraffiliation[Pegu, Amarendra] NIAID, Virol Lab, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
dc.contributor.authoraffiliation[Cooper, Arik] NIAID, Virol Lab, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
dc.contributor.authoraffiliation[Mascola, John R.] NIAID, Virol Lab, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
dc.contributor.authoraffiliation[Deleage, Claire] Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Leidos Biomed Res Inc, BG 535,POB B, Frederick, MD 21702 USA
dc.contributor.authoraffiliation[Estes, Jacob D.] Frederick Natl Lab Canc Res, AIDS & Canc Virus Program, Leidos Biomed Res Inc, BG 535,POB B, Frederick, MD 21702 USA
dc.contributor.authoraffiliation[Andrews, Sarah] NIAID, Immunol Core Sect, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
dc.contributor.authoraffiliation[McDermott, Adrian B.] NIAID, Immunol Core Sect, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
dc.contributor.authoraffiliation[Del Rio Estrada, Perla M.] Inst Nacl Enfermedades Resp, Dept Invest Enfermedades Infecciosas, Mexico City, DF, Mexico
dc.contributor.authoraffiliation[Ablanedo-Terrazas, Yuria] Inst Nacl Enfermedades Resp, Dept Invest Enfermedades Infecciosas, Mexico City, DF, Mexico
dc.contributor.authoraffiliation[Rivero, Amaranta] Inst Nacl Enfermedades Resp, Dept Invest Enfermedades Infecciosas, Mexico City, DF, Mexico
dc.contributor.authoraffiliation[Alicia Gonzalez-Hernandez, Luz] Inst Nacl Enfermedades Resp, Dept Invest Enfermedades Infecciosas, Mexico City, DF, Mexico
dc.contributor.authoraffiliation[Reyes-Teran, Gustavo] Inst Nacl Enfermedades Resp, Dept Invest Enfermedades Infecciosas, Mexico City, DF, Mexico
dc.contributor.authoraffiliation[Boritz, Eli] NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
dc.contributor.authoraffiliation[Douek, Daniel C.] NIAID, Human Immunol Sect, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA
dc.contributor.authoraffiliation[Paris, Robert] Walter Reed Army Inst Res, Silver Spring, MD 20910 USA
dc.contributor.authoraffiliation[Ruiz-Mateos, Ezequiel] Univ Seville, Lab Immunovirol, Hosp Univ Virgen Rocio, Inst Biomed Sevilla,CSIC, Seville 41013, Spain
dc.contributor.authoraffiliation[Leal, Manuel] Univ Seville, Lab Immunovirol, Hosp Univ Virgen Rocio, Inst Biomed Sevilla,CSIC, Seville 41013, Spain
dc.contributor.authoraffiliation[Docobo, Fernando] Univ Seville, Lab Immunovirol, Hosp Univ Virgen Rocio, Inst Biomed Sevilla,CSIC, Seville 41013, Spain
dc.contributor.authoraffiliation[Vagios, Ilias] Venizeleio Hosp, Dept Histopathol, Iraklion, Crete, Greece
dc.contributor.authoraffiliation[Moir, Susan] NIAID, Immunoregulat Lab, Bldg 10, Bethesda, MD 20892 USA
dc.contributor.authoraffiliation[Pantaleo, Giuseppe] Univ Lausanne, Univ Lausanne Hosp, Dept Med, Serv Immunol & Allergy,Serv Infect Dis, CH-1011 Lausanne, Switzerland
dc.contributor.authoraffiliation[Pantaleo, Giuseppe] Univ Lausanne, Univ Lausanne Hosp, Swiss Vaccine Res Inst, CH-1011 Lausanne, Switzerland
dc.contributor.authoraffiliation[Betts, Michael R.] Univ Penn, Dept Microbiol, Ctr AIDS Res, Perelman Sch Med, Philadelphia, PA 19104 USA
dc.contributor.authoraffiliation[Betts, Michael R.] Univ Penn, Inst Immunol, Perelman Sch Med, Philadelphia, PA 19104 USA
dc.contributor.authoraffiliation[Gerner, Michael Y.] Univ Washington, Dept Immunol, Seattle, WA 98109 USA
dc.contributor.funderVRC, NIAID, NIH
dc.contributor.funderBill and Melinda Gates Foundation
dc.contributor.funderNational Cancer Institute, NIH
dc.contributor.funderRedes Telematicas de Investigacion Cooperativa en Salud (RETICS; Red de SIDA)
dc.contributor.funderFondo de Investigacion Sanitaria
dc.contributor.funderNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
dc.date.accessioned2023-02-12T02:21:35Z
dc.date.available2023-02-12T02:21:35Z
dc.date.issued2017-01-18
dc.description.abstractCytolytic CD8 T cells play a crucial role in the control and elimination of virus-infected cells and are a major focus of HIV cure efforts. However, it has been shown that HIV-specific CD8 T cells are infrequently found within germinal centers (GCs), a predominant site of active and latent HIV infection. We demonstrate that HIV infection induces marked changes in the phenotype, frequency, and localization of CD8 T cells within the lymph node (LN). Significantly increased frequencies of CD8 T cells in the B cell follicles and GCs were found in LNs from treated and untreated HIV-infected individuals. This profile was associated with persistent local immune activation but did not appear to be directly related to local viral replication. Follicular CD8 (fCD8) T cells, despite compromised cytokine polyfunctionality, showed good cytolytic potential characterized by high ex vivo expression of granzyme B and perforin. We used an anti-HIV/anti-CD3 bispecific antibody in a redirected killing assay and found that fCD8 T cells had better killing activity than did non-fCD8 T cells. Our results indicate that CD8 T cells with potent cytolytic activity are recruited to GCs during HIV infection and, if appropriately redirected to kill HIV-infected cells, could be an effective component of an HIV cure strategy.
dc.identifier.doi10.1126/scitranslmed.aag2285
dc.identifier.essn1946-6242
dc.identifier.issn1946-6234
dc.identifier.unpaywallURLhttps://europepmc.org/articles/pmc5497679?pdf=render
dc.identifier.urihttp://hdl.handle.net/10668/18997
dc.identifier.wosID394447000004
dc.issue.number373
dc.journal.titleScience translational medicine
dc.journal.titleabbreviationSci. transl. med.
dc.language.isoen
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.organizationHospital Universitario Virgen del Rocío
dc.publisherAmer assoc advancement science
dc.rights.accessRightsopen access
dc.subjectHuman-immunodeficiency-virus
dc.subjectLymph-nodes
dc.subjectReplication
dc.subjectEffector
dc.subjectLymphocytes
dc.subjectActivation
dc.subjectResponses
dc.subjectTissue
dc.subjectRna
dc.subjectExpansion
dc.titleFollicular CD8 T cells accumulate in HIV infection and can kill infected cells in vitro via bispecific antibodies
dc.typeresearch article
dc.type.hasVersionAM
dc.volume.number9
dc.wostypeArticle
dspace.entity.typePublication

Files